Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| WK | WORKIVA INC | $4.38B | 56,015,581 | 83.49% | 12.75% | Net Buying | Net Selling | ||
| IAC | IAC INC | $2.89B | 80,157,271 | 89.24% | 3.49% | Net Buying | Net Buying | ||
| KAPA | KAIROS PHARMA LTD | $32.78M | 20,743,765 | 1.05% | 32.68% | Net Buying | |||
| AIOT | POWERFLEET INC | $701.91M | 133,443,292 | 78.56% | 21.44% | Net Selling | Net Buying | ||
| CNTX | CONTEXT THERAPEUTICS INC | $72.84M | 89,704,194 | 76.50% | 1.46% | Net Buying | |||
| NKTX | NKARTA INC | $139.92M | 71,024,512 | 62.30% | 37.70% | Net Selling | Net Selling | ||
| SMLR | SEMLER SCIENTIFIC INC | $420.31M | 14,804,693 | 62.05% | 37.95% | Net Buying | Net Buying | ||
| FANG | DIAMONDBACK ENERGY INC | $38.94B | 289,486,120 | 48.34% | 51.66% | Net Selling | Net Selling | ||
| PASG | PASSAGE BIO INC | $22.09M | 3,178,710 | 48.56% | 51.44% | Net Selling | Net Selling | ||
| CEVA | CEVA INC | $586.07M | 23,882,243 | 68.73% | 31.27% | Net Buying | Net Buying | ||
| DMAC | DIAMEDICA THERAPEUTICS INC | $362.34M | 51,688,913 | 16.96% | 69.86% | Net Buying | Net Buying | ||
| KRRO | KORRO BIO INC | $294.40M | 9,390,903 | 24.31% | 75.69% | Net Buying | |||
| ENTA | ENANTA PHARMACEUTICALS INC | $159.48M | 21,377,923 | 56.45% | 43.55% | Net Selling | Net Selling | ||
| PRO | PROS HOLDINGS INC | $721.60M | 48,106,454 | 47.10% | 52.90% | Net Buying | Net Buying | ||
| KYMR | KYMERA THERAPEUTICS INC | $3.38B | 71,497,597 | 75.96% | 24.04% | Net Buying | Net Buying | ||
| DNUT | KRISPY KREME INC | $532.10M | 170,000,000 | 15.93% | 84.07% | Net Selling | Net Selling | ||
| CARL | CARLSMED INC | $389.41M | 26,581,134 | 0.00% | 54.33% | Net Buying | Net Buying | ||
| MTSR | METSERA INC | $3.59B | 105,055,538 | 46.48% | 53.52% | Net Buying | Net Selling | ||
| SGMT | SAGIMET BIOSCIENCES INC | $206.84M | 32,521,599 | 34.93% | 65.07% | Net Selling | Net Selling | ||
| CZR | CAESARS ENTERTAINMENT INC | $5.39B | 207,991,539 | 77.83% | 22.17% | Net Selling | |||
| MBX | MBX BIOSCIENCES INC | $363.32M | 33,424,371 | 38.30% | 61.70% | Net Buying | |||
| ICHR | ICHOR HOLDINGS LTD | $585.97M | 34,327,355 | 69.01% | 30.99% | Net Buying | Net Buying | ||
| ESTC | ELASTIC NV | $9.38B | 106,270,940 | 57.79% | 42.21% | Net Selling | Net Selling | ||
| FLD | FOLD HOLDINGS INC | $154.41M | 46,789,930 | 4.07% | 74.59% | Net Buying | Net Buying | ||
| BNTX | BIONTECH SE | $23.53B | 240,392,622 | 22.36% | 0.00% | ||||
| ORIC | ORIC PHARMACEUTICALS INC | $1.04B | 97,122,987 | 81.27% | 18.73% | Net Selling | Net Selling | ||
| SKYW | SKYWEST INC | $4.22B | 40,378,254 | 49.61% | 50.39% | Net Selling | Net Selling | ||
| HOWL | WEREWOLF THERAPEUTICS INC | $65.39M | 45,728,999 | 42.70% | 57.30% | Net Buying | |||
| TSHA | TAYSHA GENE THERAPIES INC | $823.84M | 272,794,885 | 89.44% | 10.56% | Net Buying | Net Selling | ||
| AKRO | AKERO THERAPEUTICS INC | $3.42B | 79,717,570 | 74.93% | 25.07% | Net Buying | Net Selling | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $7.60B | 60,658,809 | 28.83% | 71.17% | Net Selling | Net Selling | ||
| MSGS | MADISON SQUARE GARDEN SPORTS CORP | $5.07B | 24,017,613 | 70.74% | 3.03% | Net Selling | |||
| UTI | UNIVERSAL TECHNICAL INSTITUTE INC | $1.48B | 54,406,215 | 70.16% | 29.84% | Net Selling | Net Buying | ||
| GFL | GFL ENVIRONMENTAL INC | $17.55B | 378,261,913 | 67.16% | 0.00% | ||||
| PXLW | PIXELWORKS INC | $53.83M | 5,335,317 | 7.93% | 92.07% | Net Selling | Net Selling | ||
| PPTA | PERPETUA RESOURCES CORP | $1.94B | 107,569,862 | 56.64% | 43.36% | Net Buying | Net Selling | ||
| ENGN | ENGENE HOLDINGS INC | $305.61M | 51,191,771 | 68.02% | 31.98% | Net Buying | |||
| CBIO | CRESCENT BIOPHARMA INC | $169.77M | 13,892,562 | 13.05% | 86.95% | ||||
| MAZE | MAZE THERAPEUTICS INC | $1.02B | 43,850,884 | 82.96% | 17.04% | ||||
| CSTL | CASTLE BIOSCIENCES INC | $627.16M | 29,008,281 | 85.56% | 14.44% | Net Selling | Net Selling | ||
| CCI | CROWN CASTLE INC | $40.75B | 435,470,061 | 76.04% | 23.96% | Net Selling | Net Selling | ||
| CHA | CHAGEE HOLDINGS LTD | $3.04B | 183,549,892 | 5.62% | 0.00% | ||||
| TYRA | TYRA BIOSCIENCES INC | $656.09M | 53,297,140 | 62.08% | 37.92% | Net Buying | Net Selling | ||
| TARA | PROTARA THERAPEUTICS INC | $121.92M | 38,581,863 | 48.28% | 51.72% | Net Buying | |||
| JCAP | JEFFERSON CAPITAL INC | $1.03B | 58,266,307 | 16.60% | 83.40% | Net Selling | Net Selling |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.